Which daily heartburn medicines are being discussed?

The article is about proton pump inhibitors, often shortened to PPIs. Common examples include omeprazole, lansoprazole, esomeprazole, pantoprazole, rabeprazole, and dexlansoprazole.

Does the 33% figure mean PPIs cause dementia?

No. The figure came from an observational study that found an association in people with more than 4.4 cumulative years of prescribed PPI use. Observational research can show a link, but it cannot prove that the medicine caused the outcome.

Did every study find the same risk?

No. A 2023 systematic review found no clear overall evidence that PPI use increases dementia risk, although it also said uncertainty remains. The fairest reading is that the evidence is mixed and should prompt review rather than panic.

What should someone do if they have taken a PPI for years?

Write down the product name, how long it has been used, whether it is prescription or OTC, and why it was started. Bring that list to a doctor, pharmacist, or qualified health professional for a medication review.

Are over-the-counter PPIs meant for daily use forever?

The FDA says OTC PPIs for frequent heartburn are intended for a 14-day course and can be used up to three times per year unless a health professional directs otherwise. Persistent symptoms deserve professional guidance.

Daily Heartburn Medicines and Dementia Risk

A pill organizer, water glass, and blank notebook arranged for a medication review. | lilicooks.com

The daily medicines behind the headline are proton pump inhibitors, often called PPIs. Examples include omeprazole, lansoprazole, esomeprazole, pantoprazole, rabeprazole, and dexlansoprazole. The best short answer is this: one major observational study found a higher dementia incidence among people with more than 4.4 cumulative years of prescribed PPI use, but the evidence does not prove that PPIs cause dementia, and other reviews have found mixed or unclear results. The useful response is to review why the medicine is being used, how long it has been needed, and whether ongoing use still fits the person’s situation.

Where the 33% figure came from

The 33% figure comes from the Atherosclerosis Risk in Communities study, published in Neurology in 2023. Researchers followed 5,712 participants who were free of dementia at the baseline visit used for this analysis. They looked at PPI use over time and compared later dementia incidence across exposure groups. People with more than 4.4 cumulative years of prescribed PPI use had a higher incidence of newly diagnosed dementia than those reporting no use, with a reported hazard ratio of 1.3 and a 95% confidence interval from 1.0 to 1.8. Importantly, current PPI use at the study visit was not significantly linked with higher dementia incidence, and shorter cumulative durations were not significant in that analysis https://pubmed.ncbi.nlm.nih.gov/37558503/.

That design matters. The study was observational, not a randomized trial. It can detect an association after adjustment for measured differences, but it cannot fully separate the medicine from the reasons people used it, their other conditions, their other medicines, or patterns of medical care. A headline that sounds like a simple cause-and-effect claim leaves out the most important nuance: the signal was tied to long cumulative exposure in one cohort, and the authors themselves said more work is needed to understand possible pathways.

An abstract illustration of a long-term health study timeline. | lilicooks.com

What PPIs are used for

PPIs reduce the amount of acid made in the stomach. MedlinePlus describes them as medicines used for acid reflux or gastroesophageal reflux disease, stomach or duodenal ulcers, and damage to the lower esophagus caused by reflux https://medlineplus.gov/ency/patientinstructions/000381.htm. The FDA explains that over-the-counter PPIs are for frequent heartburn, not immediate relief, and that OTC use is intended as a 14-day course up to three times per year unless a health professional directs otherwise https://www.fda.gov/drugs/understanding-over-counter-medicines/over-counter-otc-heartburn-treatment.

Prescription use is different from casual OTC use. Some people have clear reasons for longer-term acid suppression, such as documented esophageal injury or ulcer-related needs. Others may have started a PPI during a flare, after a hospital stay, or while taking another medicine, then simply continued it because it stayed on the medication list. That is why the most useful question is not “Is this medicine bad?” but “What is the current reason for taking it, and is that reason still present?”

Why association is not the same as proof

Dementia risk research is difficult because dementia develops over many years and is influenced by age, vascular health, education, family history, diabetes, blood pressure, smoking, alcohol use, depression, sleep, social factors, and many other variables. MedlinePlus notes that dementia is a loss of mental functions severe enough to affect daily life and that aging is the biggest risk factor, with other risks including smoking, uncontrolled diabetes, high blood pressure, heavy alcohol use, and close family history https://medlineplus.gov/dementia.html. Even strong statistical methods cannot perfectly adjust for every difference between people who take a long-term medicine and people who do not.

A practical way to read the ARIC study is to treat it as a reason for careful review, not alarm. The study does not show that every person taking a PPI faces the same increase in risk. It does not say that short-term use carried the same signal. It also does not prove that stopping a PPI would lower dementia risk. The finding is most relevant to people who have taken a prescribed PPI for years and are unsure whether there is still a clear indication.

Generic medicine boxes and a blank checklist at a pharmacy counter. | lilicooks.com

What the broader evidence says

A 2023 systematic review and meta-analysis in the British Journal of Clinical Pharmacology reviewed prospective studies on PPI use and dementia. It reported a pooled risk ratio of 1.16 for PPI use versus nonuse in the primary analysis, but its conclusion was cautious: the authors found no clear evidence for an association overall, although they also said some risk could not be ruled out and further research is warranted https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.15583. That mixed picture is exactly why a calm reading is better than a viral headline.

There are several possible reasons studies disagree. Some compare PPI users with nonusers, while others compare PPIs with H2 blockers. Some measure filled prescriptions, while others rely on medication inventories or self-report. Some account more fully for other health conditions than others. Follow-up time also matters: a study that looks at current use may answer a different question from a study that tries to estimate cumulative exposure over many years.

How to think about personal risk

For readers, the most helpful next step is a medication inventory. That means writing down the exact product name, whether it is prescription or OTC, how often it is used, how long it has been used, and why it was started. MedlinePlus advises people to talk with a health care provider if they find they need PPIs on most days https://medlineplus.gov/ency/patientinstructions/000381.htm. The FDA likewise advises reading the label, not using OTC heartburn drugs longer than directed, and talking to a health professional if symptoms persist https://www.fda.gov/drugs/understanding-over-counter-medicines/over-counter-otc-heartburn-treatment.

The review should be especially careful for older adults, people taking many medicines, and anyone who has used a PPI continuously for years. It should also account for why reflux symptoms are happening. The National Institute of Diabetes and Digestive and Kidney Diseases explains that GERD is a more severe and long-lasting form of reflux in which repeated symptoms or complications occur over time, and that care may involve lifestyle changes, OTC medicines, prescription medicines, or medical tests when symptoms do not improve https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults.

An older adult reviews a blank medication list with a health professional. | lilicooks.com

Questions worth bringing to a clinician

A good medication conversation is specific. Instead of asking whether a PPI is safe in the abstract, ask how it fits your current history. Useful questions include:

What was the original reason this PPI was started?
Is that reason still present today?
Do I have a condition where longer-term acid suppression is clearly needed?
Have my reflux symptoms changed, worsened, or become hard to explain?
Are there warning symptoms that should be checked rather than managed with OTC products?
How often should this medicine be reviewed on my medication list?

People who want more background on medicine groups and cognitive concerns can also read 8 Medication Types Linked to Dementia Risk and 7 Medication Groups That Can Affect Memory and Thinking. For older adults reviewing nutrient-related questions, B12 and Common Medications After 60 may be useful. These are not substitutes for a personal medication review, but they can help readers organize better questions before an appointment.

The bottom line

The viral version of the story is too simple. The 33% number is real within the limits of one observational study, but it applies to a specific long-duration exposure group and does not prove cause and effect. The wider research remains mixed. PPIs can be appropriate and useful, especially when there is a clear reason for them, but long-term daily use deserves periodic review. If a PPI has been part of the routine for years, the safest next step is not fear. It is a clear conversation about the indication, expected benefit, duration, and whether the plan still makes sense.

Wrap-Up

Proton pump inhibitors are common acid-reducing medicines used for reflux-related conditions and ulcers. A 2023 ARIC analysis found higher dementia incidence among participants with more than 4.4 cumulative years of prescribed PPI use, but current use and shorter durations were not significant in that study. A separate 2023 systematic review found no clear overall evidence that PPIs increase dementia risk. For readers, the practical message is to keep PPIs tied to a documented reason, review long-term daily use with a qualified clinician, and avoid making medication changes based only on a headline.

Frequently Asked Questions

→ Which daily heartburn medicines are being discussed?: The article is about proton pump inhibitors, often shortened to PPIs. Common examples include omeprazole, lansoprazole, esomeprazole, pantoprazole, rabeprazole, and dexlansoprazole.
→ Does the 33% figure mean PPIs cause dementia?: No. The figure came from an observational study that found an association in people with more than 4.4 cumulative years of prescribed PPI use. Observational research can show a link, but it cannot prove that the medicine caused the outcome.
→ Did every study find the same risk?: No. A 2023 systematic review found no clear overall evidence that PPI use increases dementia risk, although it also said uncertainty remains. The fairest reading is that the evidence is mixed and should prompt review rather than panic.
→ What should someone do if they have taken a PPI for years?: Write down the product name, how long it has been used, whether it is prescription or OTC, and why it was started. Bring that list to a doctor, pharmacist, or qualified health professional for a medication review.
→ Are over-the-counter PPIs meant for daily use forever?: The FDA says OTC PPIs for frequent heartburn are intended for a 14-day course and can be used up to three times per year unless a health professional directs otherwise. Persistent symptoms deserve professional guidance.

References

This content was developed and refined using reliable sources.

What the Dementia Research on Daily Heartburn Medicines Really Shows